| Larissa Nasisi, | |
|
1635 Mineral Spring Ave, North Providence, RI 02904-4025 | |
| (401) 349-4269 | |
| Not Available |
| Full Name | Larissa Nasisi |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1635 Mineral Spring Ave, North Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639739741 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | MHC01515 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Larissa Nasisi, 147 Dyerville Ave, Johnston, RI 02919-4412 Ph: () - | Larissa Nasisi, 1635 Mineral Spring Ave, North Providence, RI 02904-4025 Ph: (401) 349-4269 |
News Archive
New preclinical research led by Wensheng Wei from Peking University in China has proposed the development of a circular RNA vaccine. Their findings showed the circular RNA vaccine creates neutralizing antibodies and strong T-cell responses against the receptor-binding domain of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein.
More evidence has surfaced that supports the war on smoking, especially if smokers have an infant in their household. A study published today in the June issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI), found that infants with a family history of allergic disease with lower respiratory tract infections, who are exposed to secondhand smoke are at risk for longer hospital stays.
The signaling protein mTOR is a key regulator that controls cell growth. Dysfunction of mTOR increases not only the likelihood of developing cancer but also diabetes. In the current issue of the journal Cell Metabolism, Mike Hall and his team from the Biozentrum of the University of Basel describe how inhibition of mTOR signaling can impair carbohydrate metabolism and potentially lead to diabetes.
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that the U.S. Food and Drug Administration (FDA) has granted permission to the Company to initiate a Phase 1 clinical trial with its mobilization technology UMK-121.
People with Lynch syndrome have a genetic mutation that gives them a high risk of several types of cancer including bowel cancer. The genes that are damaged can't repair any errors that occur in our DNA.
› Verified 7 days ago
Celestina Okai, Counselor Medicare: Not Enrolled in Medicare Practice Location: 102 Bellevue Ave, North Providence, RI 02911 Phone: 401-837-6708 | |
Jonathan Mccarthy, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 420 Fruit Hill Ave, North Providence, RI 02911 Phone: 401-651-3702 Fax: 401-354-7986 | |
Mr. Jeffrey Leonard Bibeau, MAST Counselor Medicare: Not Enrolled in Medicare Practice Location: 429 Fruit Hill Ave, North Providence, RI 02911 Phone: 401-353-3900 Fax: 401-354-7986 | |
Mrs. Kelly Lynn Tufano, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 92 Cottage Ave, North Providence, RI 02911 Phone: 401-286-8924 | |
Miss Jennifer Mary Prendergast, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 420 Fruit Hill Ave, North Providence, RI 02911 Phone: 401-353-3900 Fax: 401-354-7986 | |
Ms. Helene Penza, MA CAGS ACS Counselor Medicare: Not Enrolled in Medicare Practice Location: 150 High Service Avenue, North Providence, RI 02911 Phone: 401-354-4318 Fax: 401-354-0018 | |
Ms. Angelica Spirito, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 420 Fruit Hill Ave., North Providence, RI 02911 Phone: 401-353-3900 Fax: 401-784-3549 |